Product Reports Resources Pricing Login Book a demo

Momenta Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2001 · IPO 2004

Biotechnology company specializing in the characterization and process engineering of complex molecules

Valuation $6.50B
Revenue $29M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Momenta Pharmaceuticals's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Momenta Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Polaris Partners
Series B+ 5 investors entered at this stage
MVM Life Science Partners
Mithra Ventures
Cardinal Partners
Atlas Venture
Massachusetts Institute of Technology

Momenta Pharmaceuticals mafia

Startups founded by Momenta Pharmaceuticals alumni

Former Momenta Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

VisterraEst. 2007
Ram SasisekharanUnited States
Signal score77
Mitra BiotechEst. 2009
MSMallik SundaramUnited States
Signal score76
Sunflower TherapeuticsEst. 2018
Kathryn GoldenUnited States
Signal score67
AffinivaxEst. 2014
Steven BruggerUnited States
Signal score61
OvaScienceEst. 2011
Christoph WestphalUnited States
Signal score61
Pandion TherapeuticsEst. 2016
ACAlan CraneUnited States
Signal score58

Book a demo to explore the full alumni network →

Global footprint

Where Momenta Pharmaceuticals has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States96%
🇮🇳 India4%
2 countries shown
Web traffic by country
1.3K monthly visits
across markets
🇺🇸 United States84.6%
🇮🇹 Italy15.4%
Top 2 markets shown

Patent intelligence

$70M patent portfolio · 58 active families

Estimated portfolio value
$70M
1.1% of market cap · 4.7× larger than top peer Anhui Anke Biotechnology ($15M)
58 active patent families
Where Momenta Pharmaceuticals innovates Amino acidCell biologyChemistryGlycanGlycoprotein

Where Momenta Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Momenta Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Momenta Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Momenta Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Momenta Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles